β-hydroxy-β-methylbutyrate enhances anti-PD1 immunotherapy in a mouse model of pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Etigunta, Suhas K. [1 ]
Coleman, Michael F. [1 ]
Pfeil, Alex J. [1 ]
Lashinger, Laura M. [2 ]
Cui, Zhengrong [2 ]
Hursting, Stephen D. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Univ Texas Austin, Austin, TX 78712 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1565
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impact of anti-PD1 immunotherapy and circulating tumor cells on progression-free survival in surgical pancreatic adenocarcinoma: a retrospective cohort study
    He, Yong-Gang
    Zhu, Yi-Nan
    Xiao, Zhou-You
    Wang, Zheng
    Wang, Chao-Qun
    Huang, Xiao-Bing
    Zheng, Lu
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2025, 21 (03) : 359 - 368
  • [22] Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma
    Oshima, Yukino
    Sano, Makoto
    Kajiwara, Ichie
    Ichimaru, Yoshimi
    Itaya, Tomoaki
    Kuramochi, Tomoya
    Hayashi, Emiko
    Kim, Jinsuk
    Kitajima, Osamu
    Masugi, Yohei
    Masamune, Atsushi
    Ijichi, Hideaki
    Ishii, Yukimoto
    Suzuki, Takahiro
    BRITISH JOURNAL OF ANAESTHESIA, 2022, 128 (04) : 679 - 690
  • [23] Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
    Doleschel, Dennis
    Hoff, Sabine
    Koletnik, Susanne
    Rix, Anne
    Zopf, Dieter
    Kiessling, Fabian
    Lederle, Wiltrud
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [24] DPP inhibition alters the CXCR3 axis and enhances NK and CD8+T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
    Fitzgerald, Allison A.
    Wang, Shangzi
    Agarwal, Veena
    Marcisak, Emily F.
    Zuo, Annie
    Jablonski, Sandra A.
    Loth, Melanie
    Fertig, Elana J.
    MacDougall, John
    Zhukovsky, Eugene
    Trivedi, Shubhendu
    Bhatia, Dimple
    O'Neill, Vince
    Weiner, Louis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [25] Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
    Dennis Doleschel
    Sabine Hoff
    Susanne Koletnik
    Anne Rix
    Dieter Zopf
    Fabian Kiessling
    Wiltrud Lederle
    Journal of Experimental & Clinical Cancer Research, 40
  • [26] Anti-GPC1 IgM activating the complement system is an effective treatment in a pancreatic ductal adenocarcinoma mouse model
    Capolla, Sara
    Busato, Davide
    Durigutto, Paolo
    Dal Bo, Michele
    Toffoli, Giuseppe
    Macor, Paolo
    IMMUNOBIOLOGY, 2023, 228 (05) : 102 - 103
  • [27] PTPN22 targeting partners with 41BB/OX40 costimulation to overcome anti-PD1 resistance in pancreatic ductal adenocarcinoma
    Charmsaz, Soren
    Gross, Nicole E.
    Lee, Jae W.
    Lin, Jianping
    Hernandez, Alexei G.
    Coyne, Erin M.
    Shin, Sarah M.
    Cannon, Courtney
    Yuan, Xuan
    Zhang, Zhong-Yin
    Jaffee, Elizabeth M.
    Ho, Won Jin
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model
    Sheriff, Lozan
    Bending, David
    STAR PROTOCOLS, 2022, 3 (01):
  • [29] Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
    Sun, Guangshun
    Liu, Hanyuan
    Zhao, Jie
    Zhang, Jinyu
    Huang, Tian
    Sun, Guoqiang
    Zhao, Siqi
    Zhang, Zihao
    Cao, Hengsong
    Rong, Dawei
    Kong, Xiangyi
    Ji, Qinghua
    Liu, Li
    Wang, Xuehao
    Tang, Weiwei
    Xia, Yongxiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
  • [30] NEOADJUVANT IMMUNOTHERAPY WITH ANTI-PD1 ALTERS THE TUMOR MICROENVIRONMENT POST SURGERY IN A MODEL OF RECURRENT GLIOBLASTOMA
    Hoang-Minh, Lan
    Doonan, Bently
    von Roemeling, Christina
    Yang, Changlin
    Shin, David
    Trivedi, Vrunda
    Karachi, Aida
    Wang, Yu
    Mitchell, Duane
    NEURO-ONCOLOGY, 2021, 23 : 168 - 168
12345